News

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...
Stock futures edged lower Monday morning as President Trump threatened an additional 10% tariff on countries supporting the ...
Glissmann, asset allocation research head at Goldman Sachs, discusses markets in the lead up to the July 9 deadline to negotiate trade deals with the US. "I think there's been a bit too much ...
A lot has been said about the emerging technology's world-changing potential: Its ability to create stunningly realistic ...
Eli Lilly is a leader in the weight loss drug market, generating blockbuster revenue. Viking Therapeutics recently launched a phase 3 trial for its weight loss candidate -- and could have a promising ...
Welcome to the Money blog, Sky News' personal finance and consumer hub. A development chef who creates biscuits for McVities ...
The improvement was largely driven by a push from Beijing last year requiring listed companies to pay dividends multiple ...
Oil prices receded in early trading on Monday after members of the Opec+ producer group on Saturday agreed to a larger than ...
Stablecoin issuers and traders are attracted by yields on offer and potential use as collateral in some derivatives transactions ...
Goldman Sachs’ estimate of its own trading and counterparty losses in the latest Dodd-Frank Act stress test (DFAST) were significantly higher than the regulators’, coinciding with a major overhaul of ...
SEBI's recent ban on Jane Street for market manipulation has sent ripples through the financial markets, with brokerages ...
Goldman Sachs said it expects a group of eight OPEC+ members to lift oil production quotas by 550,000 barrels per day in ...